Glacet-Bernard A, Mahdavi K N, Coscas G, Zourdani A, Fardeau C
University Eye Clinic, Creteil, France.
Eur J Ophthalmol. 1994 Jul-Sep;4(3):166-74. doi: 10.1177/112067219400400306.
Macular edema is still the main cause of poor visual prognosis in central retinal vein occlusion (CRVO). This study was designed to establish whether grid photocoagulation is effective in the management of this disorder.
The records of 16 patients who had undergone macular grid photocoagulation for persistent macular edema due to CRVO were reviewed retrospectively. Pre-treatment visual acuity ranged from 20/400 to 20/40, and laser treatment was done six months or more after the onset of the disease.
Biomicroscopy and fluorescein angiography showed the improvement or disappearance of macular edema in 14/16 patients (87.5%). Improved visual acuity was observed in eight (50%) and no improvement or reduced vision in the other eight (50%). A poorer prognosis was statistically correlated with older age (p < 0.03), macular ischemia (p < 0.001), foveal avascular zone larger than 1/2 disc diameter (p < 0.05) and pigmentary clumps in the foveal area (p < 0.05). Laser treatment was ineffective for most patients with systemic vascular risk factors and pre-treatment visual acuity below 20/200.
Macular grid photocoagulation may be effective for drying up, or at least reducing, macular edema due to CRVO and some improvement of vision can be expected in half the cases.
黄斑水肿仍是视网膜中央静脉阻塞(CRVO)导致视力预后不良的主要原因。本研究旨在确定格栅光凝治疗这种疾病是否有效。
回顾性分析16例因CRVO导致持续性黄斑水肿而接受黄斑格栅光凝治疗的患者记录。治疗前视力范围为20/400至20/40,激光治疗在疾病发作后6个月或更长时间进行。
生物显微镜检查和荧光素血管造影显示14/16例患者(87.5%)黄斑水肿有所改善或消失。8例(50%)患者视力提高,另外8例(50%)患者视力无改善或下降。较差的预后在统计学上与年龄较大(p < 0.03)、黄斑缺血(p < 0.001)、黄斑无血管区大于1/2视盘直径(p < 0.05)以及黄斑区色素沉着(p < 0.05)相关。对于大多数有全身血管危险因素且治疗前视力低于20/200的患者,激光治疗无效。
黄斑格栅光凝可能对干燥或至少减轻CRVO引起的黄斑水肿有效,半数病例可预期视力有所改善。